{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:31:22Z","timestamp":1772263882517,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0011250","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000}}],"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"American Leprosy Missions (ALM) and Novartis","award":["Innovation Prize FY21"],"award-info":[{"award-number":["Innovation Prize FY21"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The control of onchocerciasis currently relies on annual distribution of single dose ivermectin. Because ivermectin has minimal effects on the adult parasite, mass drug administration (MDA) campaigns against onchocerciasis require at least 15 years of annual uninterrupted ivermectin distribution. Mathematical models have predicted that short-term disruption of MDA (as was seen during COVID-19) could impacted the microfilaridermia prevalence depending on the pre-control endemicity and the histories of treatment, requiring corrective measures (such as biannual MDA) to mitigate the effect on onchocerciasis elimination. Field evidence supporting this prediction, however, has yet to be gathered. This study aimed to assess the impact of ~2 years disruption of MDA on onchocerciasis transmission indicators.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methodology<\/jats:title>\n<jats:p>A cross-sectional survey was carried out in 2021 in seven villages of Bafia and Ndikinimeki, two health districts located in the Centre Region, Cameroon, where MDA has been ongoing for two decades, but interrupted in 2020 as a response to the COVID-19 pandemic. Volunteers aged 5 years and above were enrolled for clinical and parasitological examinations for onchocerciasis. Data were compared with pre-COVID-19 prevalence and intensity of infection from the same communities to measure changes over time.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Principal findings<\/jats:title>\n<jats:p>A total of 504 volunteers (50.3% males), aged 5\u201399 years (Median: 38; IQR: 15\u201354) was enrolled in the two health districts. The overall prevalence of microfilaridermia in 2021 was similar in Ndikinimeki health district (12.4%; 95% CI: 9.7\u201315.6) and Bafia health district (15.1%; 95% CI: 11.1\u201319.8) (<jats:italic>p-value<\/jats:italic> = 0.16). Microfilaridermia prevalences were either similar between 2018 and 2021 in the communities of Ndikinimeki health district (19.3% vs 12.8% (<jats:italic>p<\/jats:italic> = 0.057) for Kiboum 1; and 23.7% vs 21.4% (<jats:italic>p<\/jats:italic> = 0.814) for Kiboum 2), or higher in 2019 compared to 2021 in the communities of Bafia health district (33.3% vs 20.0% (<jats:italic>p<\/jats:italic> = 0.035) for Biatsota). The mean microfilarial densities in these communities dropped from 5.89 (95% CI: 4.77\u20137.28) mf\/ss to 2.4 (95% CI: 1.68\u20133.45) mf\/ss (p-value &lt; 0.0001), and from 4.81 (95% CI: 2.77\u20138.31) mf\/ss to 4.13 (95% CI: 2.49\u20136.86) mf\/ss (p-value &lt; 0.02) in Bafia and Ndikinimeki health districts, respectively. Community Microfilarial Load (CMFL) dropped from 1.08\u20131.33 mf\/ss in 2019 to 0.052\u20130.288 mf\/ss in 2021 in Bafia health district while remaining stable in the Ndikinimeki health district.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion\/Significance<\/jats:title>\n<jats:p>The continued decline in prevalence and CMFL observed ~2 years after MDA disruption is consistent with mathematical predictions (ONCHOSIM) and shows that additional efforts and resources are not needed to mitigate the effects of short-term MDA disruption in highly endemic settings prior to intervention with long treatment histories.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0011250","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T17:43:50Z","timestamp":1681494230000},"page":"e0011250","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration"],"prefix":"10.1371","volume":"17","author":[{"given":"Arnauld","family":"Efon-Ekangouo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4496-6048","authenticated-orcid":true,"given":"Hugues C.","family":"Nana-Djeunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narcisse","family":"Nzune-Toche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00efssa","family":"Dongmo-Yemele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Bopda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane","family":"Ongbassomben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurentine","family":"Sumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Nutman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kamgno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"pntd.0011250.ref001","author":"World Health Organisation","year":"2019","journal-title":"Onchocerciasis"},{"key":"pntd.0011250.ref002","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0001-706X(91)90015-C","article-title":"The reproductive lifespan of Onchocerca volvulus in West African savanna","volume":"48","author":"AP Plaisier","year":"1991","journal-title":"Acta Trop"},{"key":"pntd.0011250.ref003","first-page":"27","article-title":"Observations on the reproductive biology of Onchocerca volvulus","volume":"59","author":"H. Schulz-Key","year":"1990","journal-title":"Acta Leiden"},{"key":"pntd.0011250.ref004","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/509325","article-title":"Recent Updates on Onchocerciasis: Diagnosis and Treatment","volume":"44","author":"DN Udall","year":"2007","journal-title":"Clin Infect Dis"},{"key":"pntd.0011250.ref005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1179\/136485908X337427","article-title":"The Onchocerciasis Control Programme in West Africa (OCP).","volume":"102","author":"B. Boatin","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"key":"pntd.0011250.ref006","first-page":"69","volume":"65","author":"Boussinesq M. Ivermectine","year":"2005","journal-title":"Med Trop"},{"key":"pntd.0011250.ref007","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2183\/pjab.87.13","article-title":"Ivermectin, \u201cWonder drug\u201d from Japan: the human use perspective.","volume":"87","author":"A Crump","year":"2011","journal-title":"Proc Jpn Acad Ser B"},{"key":"pntd.0011250.ref008","author":"World Health Organisation","year":"2020","journal-title":"Elimination of human onchocerciasis: progress report, 2019\u20132020."},{"key":"pntd.0011250.ref009","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1179\/000349802125000673","article-title":"APOC\u2019s strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations.","volume":"96","author":"M Homeida","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"pntd.0011250.ref010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/inthealth\/ihv038","article-title":"Community-directed interventions are practical and effective in low-resource communities: experience of ivermectin treatment for onchocerciasis control in Cameroon and Uganda, 2004\u20132010.","volume":"8","author":"MN Katabarwa","year":"2016","journal-title":"Int Health."},{"key":"pntd.0011250.ref011","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1179\/000349802125000646","article-title":"The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC).","volume":"96","author":"UV Amazigo","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"pntd.0011250.ref012","doi-asserted-by":"crossref","first-page":"311","DOI":"10.22270\/jddt.v10i3-s.4088","article-title":"COVID-19: A Global Pandemic of 21st Century.","volume":"10","author":"P Budholiya","year":"2020","journal-title":"J Drug Deliv Ther."},{"key":"pntd.0011250.ref013","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMsb2021088","article-title":"Covid-19\u2014Implications for the Health Care System","volume":"383","author":"D Blumenthal","year":"2020","journal-title":"N Engl J Med"},{"key":"pntd.0011250.ref014","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/emermed-2020-209735","article-title":"How the COVID-19 pandemic illustrated the importance of emergency medicine, and its vital role as a pillar of the healthcare system.","volume":"37","author":"EP Heymann","year":"2020","journal-title":"Emerg Med J."},{"key":"pntd.0011250.ref015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1213\/ANE.0000000000004846","article-title":"The COVID-19 Pandemic: Effects on Low- and Middle-Income Countries.","volume":"131","author":"C-L Bong","year":"2020","journal-title":"Anesth Analg."},{"key":"pntd.0011250.ref016","author":"World Health Organisation","year":"2020","journal-title":"Ending the neglect to attain the sustainable development goals: A road map for neglected tropical diseases 2021\u20132030."},{"key":"pntd.0011250.ref017","doi-asserted-by":"crossref","first-page":"e115886","DOI":"10.1371\/journal.pone.0115886","article-title":"Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment.","volume":"9","author":"LE Coffeng","year":"2014","journal-title":"PLoS One."},{"key":"pntd.0011250.ref018","doi-asserted-by":"crossref","first-page":"e0007557","DOI":"10.1371\/journal.pntd.0007557","article-title":"Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs.","volume":"13","author":"JID Hamley","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0011250.ref019","doi-asserted-by":"crossref","first-page":"e2169","DOI":"10.1371\/journal.pntd.0002169","article-title":"Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis.","volume":"7","author":"HC Turner","year":"2013","journal-title":"PLoS Negl Trop Dis."},{"key":"pntd.0011250.ref020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/trstmh\/traa193","article-title":"What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?","volume":"115","author":"JID Hamley","year":"2021","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0011250.ref021","unstructured":"Suchel J. The climates of Cameroon. PhD thesis, University of Bordeaux III. 1987."},{"issue":"1","key":"pntd.0011250.ref022","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s13071-020-04387-6","article-title":"Point prevalence mapping reveals hotspot for onchocerciasis transmission in the Ndikinimeki Health District, Centre Region, Cameroon.","volume":"13","author":"AR Aza\u2019ah","year":"2020","journal-title":"Parasit Vectors."},{"key":"pntd.0011250.ref023","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s13071-016-1868-8","article-title":"Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment.","volume":"9","author":"G-R Kamga","year":"2016","journal-title":"Parasit Vectors"},{"key":"pntd.0011250.ref024","first-page":"163","article-title":"Studies on nodules and adult Onchocerca volvulus during a nodulectomy trial in hyperendemic villages in Liberia and Upper Volta. II. Comparison of the macrofilaria population in adult nodule carriers","volume":"35","author":"EJ Albiez","year":"1984","journal-title":"Tropenmed Parasitol"},{"key":"pntd.0011250.ref025","first-page":"43","article-title":"An attempt to normalize the methodology of clinico parasitologic surveys of onchocerciasis in West-Africa","volume":"38","author":"JP Moreau","year":"1978","journal-title":"Med Trop"},{"key":"pntd.0011250.ref026","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13071-015-0817-2","article-title":"Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment.","volume":"8","author":"S Wanji","year":"2015","journal-title":"Parasit Vectors"},{"key":"pntd.0011250.ref027","first-page":"51","article-title":"A simple technique to assess the total number of Onchocerca volvulus microfilariae in skin snips","volume":"29","author":"H. Schulz-Key","year":"1978","journal-title":"Tropenmed Parasitol"},{"key":"pntd.0011250.ref028","first-page":"655","article-title":"Epidemiologic status of onchocerciasis","volume":"57","author":"A Prost","year":"1979","journal-title":"Bull World Health Organ"},{"key":"pntd.0011250.ref029","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40249-016-0160-7","article-title":"Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results","volume":"5","author":"AH Tekle","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"pntd.0011250.ref030","first-page":"203","article-title":"Etude clinique et parasitologique de l\u2019onchocercose dans huit villages de la vall\u00e9e du Mbam","author":"M Boussinesq","year":"1992","journal-title":"Bull lias doc OCEAC"},{"key":"pntd.0011250.ref031","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1098\/rstb.1999.0433","article-title":"Population biology of human onchocerciasis.","volume":"354","author":"M-G Bas\u00e1\u00f1ez","year":"1999","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"pntd.0011250.ref032","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1093\/cid\/cix616","article-title":"Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness","volume":"65","author":"M Walker","year":"2017","journal-title":"Clin Infect Dis"},{"key":"pntd.0011250.ref033","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4269\/ajtmh.2004.71.602","article-title":"The effects of long-term community level treatment with ivermectin (Mectizan) on adult Onchocerca volvulus in Latin America.","volume":"71","author":"J Mendez-Galvan","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0011250.ref034","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4269\/ajtmh.1991.45.132","article-title":"Comparison of the Effects of a Single Dose and of Four Six-Monthly Doses of Ivermectin on Adult Onchocerca volvulus","volume":"45","author":"G Zea-Flores","year":"1991","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0011250.ref035","doi-asserted-by":"crossref","first-page":"i40","DOI":"10.1093\/inthealth\/ihx054","article-title":"Alternative treatment strategies to accelerate the elimination of onchocerciasis.","volume":"10","author":"M Boussinesq","year":"2018","journal-title":"Int Health."}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0011250","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T17:54:47Z","timestamp":1682531687000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011250"}},"subtitle":[],"editor":[{"given":"Marilia S\u00e1","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0011250","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0011250","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}